Biologics and the timing of operative management of pediatric inflammatory bowel disease

• Главные авторы: Tamara Sharf (Автор), MaKayla L. O'Guinn (Автор), Olivia A. Keane (Автор), Christopher P. Gayer (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2023-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Purpose: Biologic disease-modulating antirheumatic drugs have altered the management of inflammatory bowel disease, reserving surgery for patients who fail pharmaceutical therapies. As a result of this, it may lead to the use of an increasing number of independent biologic medications before failure...